NCT02657252View on ClinicalTrials.gov

Polidocanol Versus Glucose Treatment of Telangiectasia Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions
Varicose VeinsTelangiectasis
Interventions
DRUG

Glucose

Sclerotherapy of telangiectasis in one lower limb.

DRUG

Polidocanol with Glucose

Sclerotherapy of telangiectasis in one lower limb.

Trial Locations (1)

18618687

Vascular Lab, Botucatu

All Listed Sponsors
collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

lead

UPECLIN HC FM Botucatu Unesp

OTHER

NCT02657252 - Polidocanol Versus Glucose Treatment of Telangiectasia Trial | Biotech Hunter | Biotech Hunter